GlassVC
No published image.

Kristina Burow

Managing Director · ARCH Venture Partners

Managing Director

Kristina Burow is a Managing Director at ARCH Venture Partners, shaping the firm's life sciences strategy since joining in 2002, focused on company creation and development of transformative therapies. She is a co-founder and director of Neumora Therapeutics and a director of Scholar Rock, Boundless Bio and Mirador Therapeutics, among others.

Board seats

1310 current

· PUBLIC SOURCES

Credited hits

6

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Kristina Burow, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Kristina Burow is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • Receptosacquired

    Co-founded and served as a director of Receptos, acquired by Celgene, per her ARCH bio.

    Source: archventure.com

  • Orbital Therapeuticsacquired

    Co-founded and served as a director of Orbital Therapeutics, acquired by Bristol Myers Squibb, per her ARCH bio.

    Source: archventure.com

  • Vividion Therapeuticsacquired

    Co-founded and served as a director of Vividion Therapeutics, acquired by Bayer, per her ARCH bio.

    Source: archventure.com

  • Metseraacquired

    Co-founded and served as a director of Metsera, acquired by Pfizer, per her ARCH bio.

    Source: archventure.com

  • Kythera Biopharmaceuticalsacquired

    ARCH investment she participated in; Kythera was acquired by Allergan, per her ARCH bio.

    Source: archventure.com

  • Ikariaacquired

    ARCH investment she participated in; Ikaria was acquired by Mallinckrodt, per her ARCH bio.

    Source: archventure.com

Board seats

Current board seats · 10

Former board seats · 3

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Kristina Burow. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of ARCH Venture Partners (0) →

Firm-level reviews are not attributed to Kristina Burow.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Kristina Burow — provenance: GlassVC extended catalog, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026